Interaction of heparin with two synthetic peptides that neutralize the anticoagulant activity of heparin

Biochemistry

Volumn 45, Issue 51, 2006, Pages 15740-15747

  Wang, Jing ^a,b   Rabenstein, Dallas L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Momenta Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CALORIMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEINS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

ANTICOAGULANT ACTIVITY; HEPARIN; ISOTHERMAL TITRATION CALORIMETRY (ITC); NEUTRALIZATION;

POLYSACCHARIDES;

HEPARAN SULFATE; HEPARIN; SERINE PROTEINASE; SODIUM; SYNTHETIC PEPTIDE;

AFFINITY CHROMATOGRAPHY; ANTICOAGULATION; ARTICLE; CIRCULAR DICHROISM; CIS TRANS ISOMERISM; ISOTHERMAL TITRATION CALORIMETRY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

AMINO ACID SEQUENCE; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; CHROMATOGRAPHY, AFFINITY; HEPARIN; HUMANS; LYSINE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; QUATERNARY AMMONIUM COMPOUNDS; THERMODYNAMICS;

EID: 33845935807     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061346a     Document Type: Article

References (51)

1. Rodén, L. (1989) Highlights in the History of Heparin, in Heparin: Chemical and Biological Properties, Clinical Applications (Lane, D. A., and Lindahl, U., Eds.) pp 1-23, CRC Press, Boca Raton, FL.
2. Rabenstein, D. L. (2002) Heparin and heparin sulfate: Structure and function, Nat. Prod. Rep. 19, 312-331.
3. Olivercrona, T., and Bengtsson-Olivercrona, G. (1989) Heparin and Lipases, in Heparin: Chemical and Biological Properties, Clinical Applications (Lane, D. A., and Lindahl, U., Eds.) pp 335-361, CRC Press, Boca Raton, FL.
4. Liu, G., Hultin, M., Østergaard, P., and Olivecrona, T. (1992) Interaction of size-fractionated heparins with lipoprotein lipase and hepatic lipase in the rat, Biochem. J. 285, 731-736.
5. Yu, H., Munoz, E. M., Edens, R. E., and Linhardt, R. J. (2005) Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance, Biochim. Biophys. Acta 1726, 168-176.
6. Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C., and Taylor, S. (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone, Science 221, 719-725.
7. Vlodavsky, I., Abboud-Jarrous, G., Elkin, M., Naggi, A., Casu, B., Sasisekharan, R., and Ilan, N. (2006) The impact of heparanase and heparin on cancer metastasis and angiogenesis, Pathophysiol. Haemostasis Thromb. 35, 116-127.
8. Sasisekharan, R., Shriver, Z., Venkataraman, G., and Narayanasami, U. (2002) Roles of heparan-sulfate glycosaminoglycans in cancer, Nat. Rev. Cancer 2, 521-528.
9. Berry, D., Lynn, D. M., Berry, E., Sasisekharan, R., and Langer, R. (2006) Heparin localization and fine structure regulate Burkitt's lympnoma growth, Biochem. Biophys. Res. Commun. 348, 850-856.
10. Ludwig, R. J., Alben, S., and Boehncke, W. (2006) Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities, Mini-Rev. Med. Chem. 6, 1009-1023.
11. Lin, Y.-L., Lei, H.-Y., Lin, Y.-S., Yeh, T.-M., Chen, S.-H., and Liu, H.-S. (2002) Heparin inhibits dengue-2 virus infection of five human liver cell lines, Antiviral Res. 56, 93-96.
12. Holodniy, M., Kim, S., Katzenstein, D., Konrad, M., Groves, E. T., and Merigan, T. C. (1991) Inhibition of human immunodeficiency virus gene amplification by heparin, J. Clin. Microbiol. 29, 676-679.
13. Herold, B. C., Gerber, S. I., Polonsky, T., Belval, B. J., Shaklee, P. N., and Holme, K. (1995) Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding, Virology 206, 1108-1116.
14. Howell, A. L., Taylor, T. H., Miller, J. D., Groveman, D. S., Eccles, E. H., and Zacharski, L. R. (1996) Inhibition of HIV-1 infectivity by low molecular weight heparin. Results of in vitro studies and a pilot clinical trial in patients with advanced AIDS, Int. J. Clin. Lab. Res. 26, 124-131.
15. Clayette, P., Moczar, E., Mabondzo, A., Martin, M., Toutain, B., Marce, D., and Dormont, D. (1996) Inhibition of human immunodeficiency virus infection by heparin derivatives, AIDS Res. Hum. Retroviruses 12, 63-69.
16. Conrad, H. E. (1998) Heparin-Binding Proteins, Academic Press, New York.
17. Capila, I., and Linhardt, R. J. (2002) Heparin-protein interactions, Angew. Chem., Int. Ed. 41, 390-412.
18. Mulloy, B., and Linhardt, R. J. (2001) Order out of complexity: Protein structures that interact with heparin, Curr. Opin. Struct. Biol. 11, 623-628.
19. Jin, L., Abrahams, J. P., Skinner, R., Petitou, M., Pike, R. N., and Carrell, R. W. (1997) The anticoagulant activation of antithrombin by heparin, Proc. Natl. Acad. Sci. U.S.A. 94, 14683-14688.
20. Freitas, C. F., Faro, R., Dragosavac, D., Clozel, M., De Nucci, G., and Antunes, E. (2004) Role of endothelin-1 and thromboxane A2 in the pulmonary hypertension induced by heparin-protamine interaction in anesthetized dogs, J. Cardiovasc. Pharm. 43, 106-112.
21. Chang, L. C., Lee, H. F., Yang, Z., and Yang, V. C. (2001) Low molecular weight protamine (LMWP) as a nontoxic heparin/low molecular weight heparin antidote(I): Preparation and characterization, AAPS PharmSci 3, E17.
22. Liang, J. F., Yang, V. C., and Vaynshteyn, Y. (2005) The minimal functional sequence of protamine. Biochem. Biophys. Res. Commun. 336, 653-659.
23. IIIIn-protamine, J. Appl. Physiol. 75, 963-971.
24. Schick, B. P., Maslow, D., Moshinski, A., and San Antonio, J. D. (2004) Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo, Blood 103, 1356-1363.
25. Rohde, L. H., Julian, J., Babaknia, A., and Carson, D. D. (1996) Cell surface expression of HIP, a novel heparin/heparan sulfate-binding protein, of human uterine epithelial cells and cell lines, J. Biol. Chem. 271, 11824-11830.
26. Liu, S., Zhou, F., Höök, M., and Carson, D. D. (1997) A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities, Proc. Natl. Acad. Sci. U.S.A. 94, 1739-1744.
27. Liu, S., Smith, S. E., Julian, J., Rohde, L. H., Karin, N. J., and Carson, D. D. (1996) cDNA cloning and expression of HIP, a novel cell surface heparan sulfate/heparin-binding protein of human uterine epithelial cells and cell lines, J. Biol. Chem. 271, 11817-11823.
28. Liu, S., Julian, J., and Carson, D. D. (1998) A peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment, J. Biol. Chem. 273, 9718-9726.
29. Carpino, L. A., and Man, G. Y. (1972) 9-Fluorenylmethoxycarbonyl amino-protecting group, J. Org. Chem. 37, 3404-3409.
30. Braunschweiler, L., and Ernst, R. (1983) Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy, J. Magn. Reson. 53, 521-528.
31. Bothner-By, A., Stephens, R., Lee, J., Warren, C., and Jeanloz, R. (1984) Structure determination of a tetrasaccharide: Transient nuclear Overhauser effects in the rotating frame, J. Am. Chem. Soc. 106, 811-813.
32. Neuhaus, D., and Williamson, M. (1989) The Nuclear Overhauser Effect in Structural and Conformational Analysis, pp 253-305, VCH, Weinheim, Germany.
33. Krishnamurthy, V. V. (1997) Application of semi-selective excitation sculpting for homonuclear decoupling during evolution in multi-dimensional NMR, Magn. Reson. Chem. 35, 9-12.
34. 1H NMR spectra of difficult-to-assign peptide sequences, Magn. Reson. Chem. 36, 601-607.
35. 1H NMR spectra of peptides by band-selective, homonuclear decoupling during both the evolution and acquisition periods: Application to characterization of the binding of peptides by heparin, Magn. Reson. Chem. 44, 744-752.
36. Wiseman, T., Williston, S., Brandts, J. F., and Lin, L.-N. (1989) Rapid measurement of binding constants and heats of binding using a new titration calorimeter, Anal. Biochem. 179, 131 -137.
37. Freire, E., Mayorga, O., and Straume, M. (1990) Isothermal titration, Anal. Chem. 62, 950A-959A.
38. Hari, S. P., McAllister, H., Chuang, W.-L., Christ, M. D., and Rabenstein, D. L. (2000) Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin, Biochemistry 39, 3763-3773.
39. Rabenstein, D. L., Hari, S. P., and Kaerner, A. (1997) Determination of acid dissociation constants of peptide side-chain functional groups by two-dimensional NMR, Anal. Chem. 69, 4310-4316.
40. Dyson, H. J., and Wright, P. E. (1993) Peptide conformation and protein folding, Curr. Opin. Struct. Biol. 3, 60-65.
41. Adler, A. J., Greenfield, N. J., and Fasman, G. D. (1973) Circular dichroism and optical rotatory dispersion of proteins and polypeptides, Methods Enzymol. 27, 675-735.
42. Hoke, D. E., Carson, D. D., and Höök, M. (2003) A heparin binding synthetic peptide from human HIP/RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparin, Journal of Negative Results in Biomedicine 2, 1-10.
43. Rabenstein, D. L., Robert, J. M., and Peng, J. (1995) Multinuclear magnetic resonance studies of the interaction of inorganic cations with heparin, Carbohydr. Res. 278, 239-256.
44. Manning, G. S. (1979) Counterion binding in polyelectrolyte theory, Acc. Chem. Res. 12, 443-449.
45. Manning, G. S. (1978) The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides, Q. Rev. Biophys. 11, 179-246.
46. Jordan, R. E., Favreau, L. V., Braswell, E. H., and Rosenberg, R. D. (1982) Heparin with two binding sites for antithrombin or platelet factor 4, J. Biol. Chem. 257, 400-406.
47. Ascoli, F., Botre, C, and Liquori, A. M. (1961) On the polyelectrolyte behavior of heparin. 1. Binding of sodium ions, J. Phys. Chem. 65, 1991-1992.
48. Hileman, R. E., Jennings, R. N., and Linhardt, R. J. (1998) Thermodynamic analysis of the heparin interaction with a basic cyclic peptide using isothermal titration calorimetry, Biochemistry 37, 15231-15237.
49. Olson, S. T., Halvorson, H. R., and Bjork, I. (1991) Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models, J. Biol. Chem. 266, 6342-6352.
50. Rabenstein, D. L., Bratt, P., and Peng, J. (1998) Quantitative characterization of the binding of histamine by heparin, Biochemistry 37, 14121-14127.
51. Record, T. M., Jr., Anderson, C. F., and Lohman, T. M. (1978) Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: The roles of ion association or release, screening, and ion effects on water activity, Q. Rev. Biophys. 11, 103-178.